Immunisation campaign using oral cholera vaccine Shanchol cost effective in Malawi.

Předmět:	CHOLERA vaccines ORAL vaccines IMMUNIZATION VACCINE effectiveness ECONOMIC models COST effectiveness
Zdroj:	PharmacoEconomics & Outcomes News; 3/20/2021, Vol. 874 Issue 1, p18-18, 1p
Abstrakt:	The reactive immunisation campaign using the oral cholera vaccine Shanchol, as implemented in response to a cholera outbreak in Malawi, can be considered cost effective. Cholera-related treatment costs averted by the immunisation campaign were estimated at $US79 789, and the net immunisation programme costs were estimated at $US317 569. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink